During a meeting with members of the White House COVID-19 Response Team on October 17, 2022, leaders from healthcare associations across the country were asked to educate their members and stakeholders about the importance, effectiveness and accessibility of the COVID-19 bivalent booster and the therapeutics available to treat those diagnosed with COVID-19. AMDA-The Society for Post-Acute and Long-Term Care Medicine partnered to create this toolkit for clinicians working in post-acute and long-term care settings, treating the most vulnerable of our population.

View full toolkit.